COMMUNIQUÉS West-GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04/03/2025 - 22:30

SAN FRANCISCO, March 04, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]

Enlivex Therapeutics Announces Investor Webinar to Discuss Positive Interim Data from Phase I/II Allocetra™ Trial in Knee Osteoarthritis

04/03/2025 - 22:30

Ness-Ziona, Israel, March 04, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, is pleased to invite investors to a live [...]

Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2025

04/03/2025 - 22:30

CHARLOTTE, N.C., March 04, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare [...]

Supernus to Participate in Two Upcoming Investor Conferences

04/03/2025 - 22:30

ROCKVILLE, Md., March 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]

LUKE and the American Association of Christian Counselors Announce Partnership to Expand Human Flourishing Support for Military, Veterans, First Responders, and Their Families

04/03/2025 - 22:53

ROCKLEDGE, Fla., March 04, 2025 (GLOBE NEWSWIRE) -- LUKE Holdings, Inc. (“LUKE”), a trusted leader in healthcare staffing for the U.S. Government, has joined forces with the American Association of Christian Counselors [...]

Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024

04/03/2025 - 22:55

Strong Start to 2025 with Unaudited Revenue Increases Leading to Cash Flow Positive Operating Company Results Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood [...]

Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

03/03/2025 - 15:15

BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid [...]

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

03/03/2025 - 15:27

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following a prespecified data review and recommendation by the trial’s independent Data [...]

IN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases

03/03/2025 - 15:28

Proprietary platform represents the first known approach capable of sustained γδ T cell expansion, eliminating target cells with robust potency INB-619, a next generation γδ TCE targeting CD19, eradicates B cells in [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

03/03/2025 - 15:30

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 3 March 2025 at 16.30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

Health-ISAC Releases Its 2024 Annual Report

03/03/2025 - 16:10

Insights on Achievements in Strengthening Global Health Sector Resilience ORLANDO, Fla., March 03, 2025 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center ( Health-ISAC ), the non-profit industry-led [...]

Zelluna ASA [ZLNA]: The first ever cell therapy company to list on the Oslo Stock Exchange following successful completion of the business combination and private placement

03/03/2025 - 16:46

Oslo, Norway, 03 March, 2025 - Zelluna ASA, a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, today announces the successful completion of a [...]

Le schéma thérapeutique à base de DARZALEX® (daratumumab) par voie sous-cutanée de Johnson & Johnson reçoit un avis favorable du CMUH pour les patients atteints d’un myélome multiple nouvellement diagnostiqué, quelle que soit l’éligibilité à la greffe

03/03/2025 - 16:58

S’il est approuvé, le daratumumab sera le seul anti-CD38 disponible pour tous les types de patients atteints d’un myélome multiple nouvellement diagnostiqué, faisant ainsi du daratumumab un traitement fondamental de [...]

Résultats 2024 - Progrès dans la mise en œuvre du plan FOCUS-27 soutenue par une efficacité accrue et une discipline financière

03/03/2025 - 18:35

Communiqué de presse Paris, le 3 mars 2025 Résultats 1 de l’exercice 2024 : résilience opérationnelle et forte hausse de la génération de trésorerie avant financement dans un contexte difficile Chiffre d’affaires en [...]

Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline

03/03/2025 - 18:35

Press Release Paris, 3 rd March, 2025 Full-year 2024 results 1 : Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment Net sales down 10.0% to €911.9 million, driven [...]

Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations

03/03/2025 - 18:52

Tevogen Bio will receive the remaining $8 million grant, totaling $10 million, from KRHP LLC this quarter, following a positive review of its progress, particularly in Tevogen.AI. Efficient operations with operating [...]

Instinct Science Launches Standards of Care™: The Future of Veterinary Clinical Decision Support

03/03/2025 - 20:02

PHILADELPHIA, March 03, 2025 (GLOBE NEWSWIRE) -- Instinct Science, a leader in veterinary software innovation, announces the launch of Standards of Care™ (standards.vet), a next-generation clinical decision support tool [...]

Marius Pharmaceuticals Partners with Major Academic Medical Center on Education and Research Efforts for Oral Testosterone

03/03/2025 - 21:00

RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals , a pharmaceutical company dedicated to developing innovative therapies for testosterone deficiency, has partnered with Duke University School of [...]

BioXcel Therapeutics Announces $14 Million Registered Direct Offering

03/03/2025 - 21:33

NEW HAVEN, Conn., March 03, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in [...]